PEDIATRICS Vol. 75 No. 1 January 1985, pp. 106-111
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Avery, G. B.
Right arrow Articles by Brudno, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Avery, G. B.
Right arrow Articles by Brudno, D. S.

Controlled Trial of Dexamethasone in Respirator-Dependent Infants with Bronchopulmonary Dysplasia

Gordon B. Avery MD, PhD1, Anne B. Fletcher MD1, Michael Kaplan MD1, and D. Spencer Brudno MD1

1 From the Department of Neonatology, Children's Hospital National Medical Center, and Department of Child Health and Development, George Washington University School of Medicine and Health Sciences, Washington, DC

A randomized trial was conducted of dexamethasone therapy in infants with bronchopulmonary dysplasia who were dependent on respirators and were not progressing clinically despite conventional treatment. Babies were admitted to the study if they had a roentgenogram and clinical diagnosis of bronchopulmonary dysplasia, were 2 to 6 weeks in age, weighed <1,500 g, had made no progress in weaning for the preceding five days, and were free of sepsis, patent ductus arteriosus, and congenital heart disease, and had had no intravenous fat for at least 24 hours. After parental consent was obtained, infants were randomly assigned to control or treatment groups. The study hypothesis was that with steroid treatment, babies could be weaned from the respirator within 72 hours and would show a significant improvement in lung compliance within that time. Sequential analysis exceeded criterion (P < .05) when seven consecutive untied pairs showed weaning with dexamethasone and failure to wean in control infants. Pulmonary compliance improved by 64% in the treated group and 5% in the control group (P < .01). No significant intergroup differences were noted in mortality, length of hospital stay, sepsis, hypertension, hyperglycemia, or electrolyte abnormalities. Study design permits the conclusion that dexamethasone can produce substantial short-term improvement in lung function, often permitting rapid weaning from the respirator, but long-term efficacy and safety must be demonstrated by further investigations.

Key Words: steroids • bronchopulmonary dysplasia • dexamethasone • lung • compliance

Submitted on May 21, 1984
Accepted on August 7, 1984




This article has been cited by other articles:


Home page
 PediatricsHome page
T. F. Yeh, H. C. Lin, C. H. Chang, T. S. Wu, B. H. Su, T. C. Li, S. Pyati, and C. H. Tsai
Early Intratracheal Instillation of Budesonide Using Surfactant as a Vehicle to Prevent Chronic Lung Disease in Preterm Infants: A Pilot Study
Pediatrics, May 1, 2008; 121(5): e1310 - e1318.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
T. T. Wilson, L. Waters, C. C. Patterson, C. G. McCusker, N. M. Rooney, N. Marlow, and H. L. Halliday
Neurodevelopmental and Respiratory Follow-up Results at 7 Years for Children From the United Kingdom and Ireland Enrolled in a Randomized Trial of Early and Late Postnatal Corticosteroid Treatment, Systemic and Inhaled (the Open Study of Early Corticosteroid Treatment).
Pediatrics, June 1, 2006; 117(6): 2196 - 2205.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. R. Neal Jr., G. Weidemann, M. Kabbaj, and D. M. Vazquez
Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R375 - R385.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
T. F. Yeh, Y. J. Lin, H. C. Lin, C. C. Huang, W. S. Hsieh, C. H. Lin, and C. H. Tsai
Outcomes at School Age after Postnatal Dexamethasone Therapy for Lung Disease of Prematurity
N. Engl. J. Med., March 25, 2004; 350(13): 1304 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
O Baud
Postnatal steroid treatment and brain development
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2004; 89(2): F96 - F100.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. B. Mustafa, R. J. DiGeronimo, J. A. Petershack, J. L. Alcorn, and S. R. Seidner
Postnatal glucocorticoids induce {alpha}-ENaC formation and regulate glucocorticoid receptors in the preterm rabbit lung
Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L73 - L80.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
Statement on the Care of the Child with Chronic Lung Disease of Infancy and Childhood
Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 356 - 396.
[Full Text] [PDF]

Home page
 NeoReviewsHome page
B. A. Banks
Postnatal Dexamethasone for Bronchopulmonary Dysplasia: A Systematic Review and Meta-analysis of 20 Years of Clinical Trials
NeoReviews, February 1, 2002; 3(2): e24 - 34.
[Full Text]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. B. Flagel, D. M. Vazquez, S. J. Watson Jr., and C. R. Neal Jr.
Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R55 - R63.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
The Vermont Oxford Network Steroid Study Group
Early Postnatal Dexamethasone Therapy for the Prevention of Chronic Lung Disease
Pediatrics, September 1, 2001; 108(3): 741 - 748.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
R. J. Couser, R. E. Hoekstra, T. B. Ferrara, G. B. Wright, A. K. Cabalka, and J. E. Connett
Neurodevelopmental Follow-up at 36 Months' Corrected Age of Preterm Infants Treated With Prophylactic Indomethacin
Arch Pediatr Adolesc Med, June 1, 2000; 154(6): 598 - 602.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. A. Sinkin, H. S. Dweck, M. J. Horgan, K. J. Gallaher, C. Cox, W. M. Maniscalco, P. R. Chess, C. T. D'Angio, R. Guillet, J. W. Kendig, et al.
Early Dexamethasone---Attempting To Prevent Chronic Lung Disease
Pediatrics, March 1, 2000; 105(3): 542 - 548.
[Abstract] [Full Text]

Home page
 PediatricsHome page
B. J. Stoll, M. Temprosa, J. E. Tyson, L.-A. Papile, L. L. Wright, C. R. Bauer, E. F. Donovan, S. B. Korones, J. A. Lemons, A. A. Fanaroff, et al.
Dexamethasone Therapy Increases Infection in Very Low Birth Weight Infants
Pediatrics, November 1, 1999; 104(5): 63e - 63.
[Abstract] [Full Text]

Home page
 PediatricsHome page
C. T. Peng, H. C. Lin, Y. J. Lin, C. H. Tsai, and T. F. Yeh
Early Dexamethasone Therapy and Blood Cell Count in Preterm Infants
Pediatrics, September 1, 1999; 104(3): 476 - 481.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
S. B. Amin, R. A. Sinkin, M. P. McDermott, and J. W. Kendig
Lipid Intolerance in Neonates Receiving Dexamethasone for Bronchopulmonary Dysplasia
Arch Pediatr Adolesc Med, August 1, 1999; 153(8): 795 - 800.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
T. M. O'Shea, J. M. Kothadia, K. L. Klinepeter, D. J. Goldstein, B. G. Jackson, and R. G. Weaver
Randomized Placebo-controlled Trial of a 42-Day Tapering Course of Dexamethasone to Reduce the Duration of Ventilator Dependency in Very Low Birth Weight Infants: Outcome of Study Participants at 1-Year Adjusted Age
Pediatrics, July 1, 1999; 104(1): 15 - 21.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
T F Fok, K Lam, M Dolovich, P C Ng, W Wong, K L Cheung, and K W So
Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 1999; 80(3): 203F - 208.
[Abstract] [Full Text]

Home page
 PediatricsHome page
J. M. Kothadia, T. M. O'Shea, D. Roberts, S. T. Auringer, R. G. Weaver, and I.{s. a. R. G. Dillard
Randomized Placebo-controlled Trial of a 42-Day Tapering Course of Dexamethasone to Reduce the Duration of Ventilator Dependency in Very Low Birth Weight Infants
Pediatrics, January 1, 1999; 104(1): 22 - 27.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
W. NIKISCHIN, T. GERHARDT, R. EVERETT, and E. BANCALARI
A New Method to Analyze Lung Compliance When Pressure-Volume Relationship Is Nonlinear
Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1052 - 1060.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
A. Pellicer, F. Gayá, T. A Stiris, J. Quero, and F. Cabañas
Cerebral haemodynamics in preterm infants after exposure to dexamethasone
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 1998; 79(2): 123F - 128.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
T. Bhuta and A. Ohlsson
Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 1998; 79(1): 26F - 33.
[Abstract] [Full Text]

Home page
 PediatricsHome page
T. F. Yeh, Y. J. Lin, C. C. Huang, Y. J. Chen, C. H. Lin, H. C. Lin, W. S. Hsieh, and Y. J. Lien
Early Dexamethasone Therapy in Preterm Infants: A Follow-up Study
Pediatrics, May 1, 1998; 101 (5): e7 - e7.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
C. Kuschel, N. Evans, and A. Lam
Prediction of individual response to postnatal dexamethasone in ventilator dependent preterm infants
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 1998; 78(3): 199F - 203.
[Abstract] [Full Text]

Home page
 NEJMHome page
L.-A. Papile, J. E. Tyson, B. J. Stoll, L. L. Wright, E. F. Donovan, C. R. Bauer, H. Krause-Steinrauf, J. Verter, S. B. Korones, J. A. Lemons, et al.
A Multicenter Trial of Two Dexamethasone Regimens in Ventilator-Dependent Premature Infants
N. Engl. J. Med., April 16, 1998; 338(16): 1112 - 1119.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
T. F. Yeh, Y. J. Lin, W. S. Hsieh, H. C. Lin, C. H. Lin, J. Y. Chen, H. A. Kao, and C. H. Chien
Early Postnatal Dexamethasone Therapy for the Prevention of Chronic Lung Disease in Preterm Infants With Respiratory Distress Syndrome: A Multicenter Clinical Trial
Pediatrics, October 1, 1997; 100(4): e3 - e3.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
J. Vyas and S. Kotecha
Effects of antenatal and postnatal corticosteroids on the preterm lung
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 1997; 77(2): 147F - 150.
[Full Text]